Dr. Lal PathLabs Limited (BOM:539524)
India · Delayed Price · Currency is INR 1,418.40
+20.50 (1.47%)
At close: Jan 22, 2026
Dr. Lal PathLabs Employees
Dr. Lal PathLabs had 4,980 employees as of March 31, 2025. The number of employees increased by 881 or 21.49% compared to the previous year.
Employees
4,980
Change (1Y)
881
Growth (1Y)
21.49%
Revenue / Employee
5.22M INR
Profits / Employee
1.07M INR
Market Cap
230.00B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,980 | 881 | 21.49% |
| Mar 31, 2024 | 4,099 | 51 | 1.26% |
| Mar 31, 2023 | 4,048 | -62 | -1.51% |
| Mar 31, 2022 | 4,110 | 114 | 2.85% |
| Mar 31, 2021 | 3,996 | 73 | 1.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Thyrocare Technologies | 1,822 |
| Chandan Healthcare | 1,192 |
| Star Imaging and Path Lab | 211 |
| Nidan Laboratories and Healthcare | 163 |
| Clinitech Laboratory | 148 |
| Aspira Pathlab & Diagnostics | 141 |
| Invicta Diagnostic | 105 |
| Gian Life Care | 24 |
Dr. Lal PathLabs News
- 6 weeks ago - Dr. Lal PathLabs fixes December 19 as record date for 1:1 bonus issue - Business Upturn
- 2 months ago - Dr. Lal PathLabs Ltd (BOM:539524) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 3 months ago - Q2 2026 Dr. Lal PathLabs Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) Q2 2026 Earnings Report Preview: What To Expect - GuruFocus
- 7 months ago - Dr Lal PathLabs, Metropolis Healthcare shares decline as Amazon Diagnostics enters market - Business Upturn
- 7 months ago - Dr Lal PathLabs shares decline 2% as Amazon enters diagnostics segment with doorstep lab tests - Business Upturn
- 9 months ago - Dr. Lal PathLabs Q4 FY25: Revenue up 10.48% to 602.6 crore, Net profit surges 81% YoY - Business Upturn
- 1 year ago - Dr Lal Path Labs stock jumps 3.46% after strong Q2 earnings and positive brokerage calls - Business Upturn